Lancaster Urology — Lancaster, Pennsylvania

Public research footprint of Lancaster Urology, compiled from the ClinicalTrials.gov public registry.

Registered studies

Active

Recruiting now

Completed

Stopped or withdrawn

Most-studied conditions

Prostate Cancer · Overactive Bladder · High-risk Non-muscle Invasive Bladder Cancer · Nonmetastatic Castration-Resistant Prostate Cancer

Recently updated registry entries

NCT07745361 — Study of Oral MRT-2359 With Apalutamide in Prostate Cancer (Recruiting)
NCT03748641 — A Study of Niraparib in Combination With Abiraterone Acetate and Prednisone Versus… (Active Not Recruiting)
NCT03711032 — Efficacy and Safety of Pembrolizumab (MK-3475) in Combination With Bacillus… (Active Not Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Lancaster Urology?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 04, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.